BODI is an implant prescription and supply chain revolutionizing service. BODI is bringing accountability to the industry for surgical implants. It lowers both costs and risks for implant manufacturers, distributors, healthcare providers, insurers, and ultimately patients. The purpose of BODI is to provide transparency and safety when handling surgical devices and ultimately reduce costs for members, surgeons, and insurers. Medwell's BODI reduces the need for error-prone data entry and provides a solution that is completely automated throughout the chain of custody and beyond. By implementing our BODI tracking system, hospitals, surgery, and manufacturers will recognize annual savings while meeting strict compliance regulations and improving patient outcomes. By 2025, the current database system will encompass “blockchain” technologic capabilities to further enhance the system for all users.

A heart prosthesis that includes at least one information marker and methods of using the heart prosthesis are disclosed. The at least one information marker can indicate any suitable information associated with the heart prosthesis, e.g., one or more of a manufacturer, type, model, feature, size, and date. And the heart prosthesis can include any suitable prosthesis, e.g., a prosthetic heart valve or an annuloplasty prosthesis.

The invention relates to an ophthalmological implant (100) with an optically imaging element (110), a digital product identifier (130) being arranged on the optically imaging element. The invention additionally relates to a corresponding method for producing the implant and to a machine reading system (200) for detecting and decoding the digital product identifier. The aim of the invention is to provide an ophthalmological implant and a method for producing same, said method allowing a unique and complete product identifier and a check thereof using simple means at any point in time. This is achieved by an ophthalmological implant with a digital product identifier (130) which is implemented by means of an encoded point grid (135) of identifier points (57), said point grid being machine-readable in the visible light range and having one irregular semi-random character.

The invention relates to a modular humeral prosthesis for an inverse shoulder prosthesis, comprising an anatomical shaft (1) and a separable epiphyseal head (2) which may be angularly orientated by rotation about the longitudinal axis (XX) of the anatomical shaft. The anatomical shaft and the epiphyseal head comprise complementary angular indexing means (11, 28) for relative rotational fixation.

The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes a pharmaceutical for use by a male and a first label coupled to the first package, wherein at least one of the first package and first label includes a male specifier and a recommended male dosage. The second package includes a pharmaceutical for use by a female and a second label coupled to the second package, wherein at least one of the second package and second label includes a female specifier and a recommended female dosage.

A delivery catheter for a stent. The delivery catheter may comprise a distal end and a proximal end. The distal end includes a stent attachment region adapted to receive a stent. The stent may be of the self-expanding type. The catheter further comprises a handle at its proximal end and at least one sheath which may at least partially circumferentially cover said stent such as to retain it in a collapsed configuration. The sheath is coupled at its proximal end to an actuator located on said handle portion. The catheter further comprises at least one radio-opaque indicator for indicating a rotational orientation of the delivery catheter and/or the stent when observed using medical imaging during implantation of the stent.

The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes a pharmaceutical for use by a male and a first label coupled to the first package, wherein at least one of the first package and first label includes a male specifier and a recommended male dosage. The second package includes a pharmaceutical for use by a female and a second label coupled to the second package, wherein at least one of the second package and second label includes a female specifier and a recommended female dosage.

A hybrid prosthetic heart valve configured to replace a native heart valve and having a support frame configured to be expanded post implant in order to receive and/or support an expandable prosthetic heart valve therein (a valve-in-valve procedure). The prosthetic heart valve may be configured to have a generally rigid and/or expansion-resistant configuration when initially implanted to replace a native valve (or other prosthetic heart valve), but to assume a generally expanded form when subjected to an outward force such as that provided by a dilation balloon or other mechanical expander. An inflow stent frame is expandable for anchoring the valve in place, and may have an outflow end that is collapsible for delivery and expandable post-implant to facilitate a valve-in-valve procedure.

A method of tracking a medical device includes creating a patient profile; creating an operating profile with at least one identified surgical site; providing a tracking assembly including a reader with a scanner, a housing enclosing the scanner and a medical drape; placing a medical device having an identifier over the reader; scanning the identifier of the medical device to electronically record the medical device data; associating the scanned medical device data with the at least one surgical site; and using the medical device on a patient on the at least one surgical site.

A carrier for retaining a plurality of implants each comprising a structurally encoded pin, the structurally encoded pin having a shape or surface characteristics discernable by an imaging modality such as x-ray, fluoroscopy, computed tomography, electromagnetic radiation, ultrasound, visible light, UV light, magnetic resonance imaging, positron emission tomography and neutron imaging, from outside the carrier, the shape or surface characteristics representing structurally encoded data. The invention further discloses a carrier for viewing a plurality of implants, and associated reading systems for reading a plurality of implants. Finally, the invention discloses methods for reading a plurality of implantable devices retained within a carrier.